Results 181 to 190 of about 3,069,601 (247)

Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as treatment for HER2-expressing advanced urothelial cancer in China. [PDF]

BMJ Open
Jia Y, Zhu L, Kang S, Wang X.
europepmc   +1 more source

Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Urachal carcinoma is a rare and aggressive malignancy with no established systemic therapy after platinum failure. Evidence for immune checkpoint inhibitors (ICIs) remains limited, particularly in tumors without established favorable biomarkers such as microsatellite instability‐high status or high tumor mutational burden.
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Takashi Fujita   +4 more
wiley   +1 more source

Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer. [PDF]

Bladder Cancer
Malshy K, Messing EM.
europepmc   +1 more source

Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle‐Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab‐Gemcitabine‐Cisplatin Versus Gemcitabine‐Cisplatin: A Systematic Review and Network Meta‐Analysis of Randomised Controlled Trials

International Journal of Cancer, Volume 159, Issue 8, Page 1962-1973, 15 October 2026.
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold, Gloria Baumann, Victoria Luise Simone Wieland, Nicolas Carl, Luisa Vivienne Renner, Alexander Studier‐Fischer, Hanna Menold, Stefanie Zschäbitz, Frederik Wessels, Niklas Westhoff, Maurice Stephan Michel, Karl‐Friedrich Kowalewski, Caelán Max Haney‐Aubert   +12 more
wiley   +1 more source

Urine Methylation Test for Urothelial Cancer Diagnosis and Surveillance.

JAMA Netw Open
Wu Y, Han W, Xiong S, He Y, He S, Dong L, Li T, Li Z, Li X, Feng N, Zhou L, Tang Q, Zhang X, Xu W, Gong Y, Li X.   +15 more
europepmc   +1 more source

Real-world treatment patterns for metastatic urothelial cancer in 5 European countries: EVEREST 2. [PDF]

Future Oncol
De Santis M, Milloy N, Walley M, Simpson A, Forshaw C, Vuillet M, Strunz-McKendry T, Kim J, Thomas MC.   +8 more
europepmc   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, Volume 13, Issue 10, Page 2036-2045, October 2026.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

SEOM-SOGUG clinical guideline for urothelial cancer (2025). [PDF]

Clin Transl Oncol
Puente J, Rodríguez-Vida A, Sevillano E, Estévez SV, Fernández CÁ, Chirivella I, Climent MÁ, Fernández O, de Liaño AG, Valderrama BP.   +9 more
europepmc   +1 more source

Modeling Catheter‐Associated Bladder Mucosal Adhesion and Microtrauma Using a Human Urothelial Microtissue Model

Advanced NanoBiomed Research, Volume 6, Issue 10, October 2026.
Intermittent catheter use can damage the urinary tract and predispose to infection. We deployed a complex human urothelial model to investigate. Catheter contact induced compressive and shear stress causing umbrella cell disruption, reduced barrier function, inflammation and increased cell adhesion to the catheter surface.
Nazila V. Jafari, Jennifer L. Rohn
wiley   +1 more source

Kidney-Sparing Approaches in Upper Tract Urothelial Cancer: A Narrative Review. [PDF]

Cureus
Kefalas C, Datseris N, Sitaridis K, Mourtzilas E, Papalakis A.   +4 more
europepmc   +1 more source